相似文献
1
Detection of antibodies to human herpesvirus 8 in Italian children: evidence for horizontal transmission.
Br J Cancer. 2000 Feb;82(3):702-4. doi: 10.1054/bjoc.1999.0983.
2
Comparison of human herpesvirus 8 and Epstein-Barr virus seropositivity among children in areas endemic and non-endemic for Kaposi's sarcoma.
J Med Virol. 2004 Jan;72(1):126-31. doi: 10.1002/jmv.10548.
3
Human herpesvirus 8: serovprevalence and correlates in tumor patients from Xinjiang, China.
J Med Virol. 2007 Feb;79(2):161-6. doi: 10.1002/jmv.20730.
4
Prevalence, incidence and correlates of HHV-8/KSHV infection and Kaposi's sarcoma in renal and liver transplant recipients.
J Infect. 2001 Oct;43(3):195-9. doi: 10.1053/jinf.2001.0899.
5
High prevalence of human herpesvirus 8 (HHV-8) infection in south Texas children.
J Med Virol. 2002 Aug;67(4):542-8. doi: 10.1002/jmv.10136.
6
Fatal disseminated Kaposi's sarcoma following human herpesvirus 8 primary infections in liver-transplant recipients.
Liver Transpl. 2004 Feb;10(2):295-300. doi: 10.1002/lt.20058.
7
Antibodies to human herpesvirus type 8 in the general population and in Kaposi's sarcoma patients.
Lancet. 1996 Sep 28;348(9031):858-61. doi: 10.1016/S0140-6736(96)03240-0.
8
Respective roles of serological status and blood specific antihuman herpesvirus 8 antibody levels in human herpesvirus 8 intrafamilial transmission in a highly endemic area.
Cancer Res. 2004 Dec 1;64(23):8782-7. doi: 10.1158/0008-5472.CAN-04-2000.
9
Increasing probability of mother-to-child transmission of HHV-8 with increasing maternal antibody titer for HHV-8.
N Engl J Med. 1999 Jun 17;340(24):1923. doi: 10.1056/NEJM199906173402414.
10
Demographic indicators and risk of infection with human herpesvirus type 8 in Central Italy.
Infection. 2007 Feb;35(1):22-5. doi: 10.1007/s15010-007-5123-2.
引用本文的文献
1
Human herpesvirus-6, HHV-8 and parvovirus B19 after allogeneic hematopoietic cell transplant: the lesser-known viral complications.
Curr Opin Infect Dis. 2024 Aug 1;37(4):245-253. doi: 10.1097/QCO.0000000000001020. Epub 2024 May 6.
2
Today's Kaposi sarcoma is not the same as it was 40 years ago, or is it?
J Med Virol. 2023 May;95(5):e28773. doi: 10.1002/jmv.28773.
3
Risk Factors for Kaposi's Sarcoma-Associated Herpesvirus DNA in Blood and in Saliva in Rural Uganda.
Clin Infect Dis. 2020 Aug 14;71(4):1055-1062. doi: 10.1093/cid/ciz916.
4
HHV-8 Seroprevalence and Genotype Distribution in Africa, 1998⁻2017: A Systematic Review.
Viruses. 2018 Aug 27;10(9):458. doi: 10.3390/v10090458.
5
Age of Infection with Kaposi Sarcoma-Associated Herpesvirus and Subsequent Antibody Values Among Children in Uganda.
Pediatr Infect Dis J. 2018 Aug;37(8):e225-e228. doi: 10.1097/INF.0000000000001909.
6
Kaposi`s sarcoma associated herpesvirus infection among female sex workers and general population women in Shanghai, China: a cross-sectional study.
BMC Infect Dis. 2014 Feb 5;14:58. doi: 10.1186/1471-2334-14-58.
7
Update on KSHV epidemiology, Kaposi Sarcoma pathogenesis, and treatment of Kaposi Sarcoma.
Cancer Lett. 2011 Jun 28;305(2):150-62. doi: 10.1016/j.canlet.2011.02.006. Epub 2011 Mar 4.
8
Delayed-type hypersensitivity in classic Kaposi sarcoma patients and controls.
Br J Cancer. 2011 Feb 1;104(3):433-6. doi: 10.1038/sj.bjc.6606088. Epub 2011 Jan 18.
9
Kaposi's Sarcoma Associated-Herpes Virus (KSHV) Seroprevalence in Pregnant Women in South Africa.
Infect Agent Cancer. 2010 Aug 31;5:14. doi: 10.1186/1750-9378-5-14.
10
Cause-specific mortality in classic Kaposi's sarcoma: a population-based study in Italy (1995-2002).
Br J Cancer. 2009 Oct 6;101(7):1085-90. doi: 10.1038/sj.bjc.6605265. Epub 2009 Aug 25.
Zotero 插件